MARCH - MAY - 20235TOP 10TECH OUTLOOKDRUG DISCOVERYAND DEVELOPMENTSOLUTIONS PROVIDERS - 2023CXO INSIGHTSLAST WORDC O NT E NT SInnovation vs Validation in Early Drug DiscoveryCarlos Pedraza, PhD. Director of CNS Biology,Alkermes19Drug Delivery as a TherapeuticEnabling TechnologyVincent Ling, Senior Director, Center for External Innovation (Business Development), Takeda Pharmaceuticals22The Need for Innovationin Drug DiscoveryDarryl B. McConnell, SVP, Research Site Head Austria, Boehringer Ingelheim RCV GmbH & Co KG25How to efficiently use Dose- Exposure-Response information and modern tools in DMPK and Safety sciences in drug discovery?Antti Haapalinna, Vice President, External Science and Partnering,R&D,Orion Corporation27Accelerating drug development of novel targeted therapies through histology-agnostic oncology clinical trialsHua Gong, M.D., Ph.D., SVP, Global Head of Translational Medicine and Clinical Biomarker,Zai Lab38CHEMWERTHHTG Molecular DiagnosticsNoveome BiotherapeuticsPeter J. Werth, Chief Executive OfficerJohn Lubniewski, President and CEOPatrick T. Welch,CEOLarry R. Brown,Chief Scientific Officer182426FEATURED COMPANIES
< Page 4 | Page 6 >